The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Cardinal Health Inc

NYSE: CAH
Last

(U.S.) $80.17

Today's change-2.10 -2.55%
Updated September 1 2:58 PM EDT. Delayed by at least 15 minutes.
 

Cardinal Health Inc

NYSE: CAH
Last

(U.S.) $80.17

Today's change-2.10 -2.55%
Updated September 1 2:58 PM EDT. Delayed by at least 15 minutes.

Cardinal Health Inc down (U.S.)$2.10

Cardinal Health Inc is sharply lower today, dropping (U.S.)$2.10 or 2.55% to (U.S.)$80.17. Over the last five days, shares have gained 0.94%, but are currently unchanged over the last year to date. Shares have outperformed the S&P 500 by 12.82% during the last year.

Key company metrics

  • Open(U.S.) $80.46
  • Previous close(U.S.) $82.27
  • High(U.S.) $81.42
  • Low(U.S.) $79.76
  • Bid / Ask(U.S.) $80.15 / (U.S.) $80.19
  • YTD % change-0.69%
  • Volume1,918,115
  • Average volume (10-day)3,770,394
  • Average volume (1-month)2,740,619
  • Average volume (3-month)2,717,260
  • 52-week range(U.S.) $71.72 to (U.S.) $91.91
  • Beta0.61
  • Trailing P/E22.15×
  • P/E 1 year forward16.44×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.55
  • Dividend yield1.93%
  • Trailing EPS(U.S.) $3.62
Updated September 1 2:58 PM EDT. Delayed by at least 15 minutes.
S&P TSX2.54%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue27,54825,37525,53724,070
Total other revenue--------
Total revenue27,54825,37525,53724,070
Gross profit1,4581,4591,4541,341
Total cost of revenue26,09023,91624,08322,729
Total operating expense26,99024,78425,05123,604
Selling / general / administrative750803815775
Research & development--------
Depreciation / amortization91776053
Interest expense (income), net operating--------
Unusual expense (income)59-129347
Other operating expenses, total--------
Operating income558591486466
Interest income (expense), net non-operating-36-35-36-34
Gain (loss) on sale of assets--------
Other--------
Income before tax523558451435
Income after tax292365289266
Income tax, total231193162169
Net income295365289266
Total adjustments to net income--------
Net income before extra. items292365289266
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items292365289266
Inc. avail. to common incl. extra. items295365289266
Diluted net income295365289266
Dilution adjustment0------
Diluted weighted average shares332334334340
Diluted EPS excluding extraordinary itemsvalue per share0.881.090.870.78
Dividends per sharevalue per share0.340.340.340.34
Diluted normalized EPSvalue per share0.981.071.040.87